Seminars in Hematology
Volume 40, Issue 4 , Pages 281-295 , October 2003

Gene expression profiling as a tool for the diagnosis of acute leukemias

  • Torsten Haferlach

      Affiliations

    • Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
    • Corresponding Author InformationAddress correspondence to Torsten Haferlach, MD, Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Großhadern, 81366 München, Germany
    • ,
  • Alexander Kohlmann

      Affiliations

    • Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
    • ,
  • Wolfgang Kern

      Affiliations

    • Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
    • ,
  • Wolfgang Hiddemann

      Affiliations

    • Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
    • ,
  • Susanne Schnittger

      Affiliations

    • Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
    • ,
  • Claudia Schoch

      Affiliations

    • Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany

References 

  1. Aalto Y, El Rifa W, Vilpo L, et al.  Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia. 2001;15:1721–1728
  2. Alizadeh AA, Eisen MB, Davis RE, et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511
  3. Armstrong SA, Staunton JE, Silverman LB, et al.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002;30:41–47
  4. Ashburner M, Ball CA, Blake JA, et al.  Gene ontology (Tool for the unification of biology. The Gene Ontology Consortium). Nat Genet. 2000;25:25–29
  5. Brazma A, Hingamp P, Quackenbush J, et al.  Minimum information about a microarray experiment (MIAME)—Toward standards for microarray data. Nat Genet. 2001;29:365–371
  6. Brown MP, Grundy WN, Lin D, et al.  Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA. 2000;97:262–267
  7. Cheok MH, Yang W, Pui CH, et al.  Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet. 2003;34:85–90
  8. Cohen N, Rozenfeld-Granot G, Hardan I, et al.  Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene (Expression profiling, resistance to interferon therapy, and poor prognosis). Cancer Genet Cytogenet. 2001;128:114–119
  9. Dahlquist KD, Salomonis N, Vranizan K, et al.  GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet. 2002;31:19–20
  10. Debernardi S, Lillington DM, Chaplin T, et al.  Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer. 2003;37:149–158
  11. Doniger SW, Salomonis N, Dahlquist KD, et al.  MAPPFinder (Using gene ontology and GenMAPP to create a global gene-expression profile from microarray data). Genome Biol. 2003;4:R7.1–R7.12
  12. Eisen MB, Spellman PT, Brown PO, et al.  Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863–14868
  13. Fenaux P, Le Deley MC, Castaigne S, et al.  Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia (Results of a multicenter randomized trial. European APL Group). Blood. 1993;82:3241–3249
  14. Furey TS, Cristianini N, Duffy N, et al.  Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics. 2000;16:906–914
  15. Golub TR, Slonim DK, Tamayo P, et al.  Molecular classification of cancer (class discovery and class prediction by gene expression monitoring). Science. 1999;286:531–537
  16. Haferlach T, Kohlmann A, Dugas M, et al.  Gene expression profiling is able to reproduce different phenotypes in AML as defined by the FAB classification. Blood. 2002;100:195a; (suppl 1, abstr)
  17. Haferlach T, Kohlmann A, Dugas M, et al.  The diagnosis of 14 specific subtypes of leukemia is possible based on gene expression profiles (A study on 263 patients with AML, ALL, CML, or CLL). Blood. 2002;100:139a; (suppl 1, abstr)
  18. Haferlach T, Schnittger S, Kohlmann A, et al.  Genetic profiling in acute monoblastic versus acute monocytic leukemia (A gene expression study on 22 patients). Blood. 2002;100:139a; (suppl 1, abstr)
  19. Haferlach T, Schoch C. Modern techniques in leukemia diagnosis. Internist. 2002;43:1190–1202
  20. Haferlach T, Schoch C, Schnittger S, et al.  Distinct genetic patterns can be identified in acute monoblastic and acute monocytic leukaemia (FAB AML M5a and M5b) (A study of 124 patients). Br J Haematol. 2002;118:426–431
  21. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning. New York, NY: Springer-Verlag; 2001;
  22. Hofmann WK, de Vos S, Elashoff D, et al.  Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles (A gene-expression study). Lancet. 2002;359:481–486
  23. Hofmann WK, de Vos S, Komor M, et al.  Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood. 2002;100:3553–3560
  24. Holloway AJ, van Laar RK, Tothill RW, et al.  Options available—from start to finish—for obtaining data from DNA microarrays II. Nat Genet. 2002;32(suppl):481–489
  25. Jaffe ES, Harris NL, Stein H. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2001;
  26. Jelinek DF, Tschumper RC, Stolovitzky GA, et al.  Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res. 2003;1:346–361
  27. Kantarjian H, Sawyers C, Hochhaus A, et al.  Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002;346:645–652
  28. Kern W, Kohlmann A, Wuchter C, et al: Correlation of protein expression and gene expression in acute leukemia. Cytometry (in press)
  29. Klein U, Tu Y, Stolovitzky GA, et al.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625–1638
  30. Kohlmann A, Dugas M, Schoch C, et al.  Gene expression profiles of distinct AML subtypes in comparison to normal bone marrow. Blood. 2001;98:91a; (suppl 1, abstr)
  31. Kohlmann A, Dugas M, Schoch C, et al.  Gene expression profiles of distinct cytogenetic AML subtypes as defined by the new WHO classification: A study of 45 patients. 2002; Presented at the Oncogenomics Conference 2002. Dublin, Ireland, May 1–5
  32. Kohlmann A, Schoch C, Dugas M, et al.  Gene expression profiles of t(11q23)/MLL positive ALL and AML. Blood. 2002;100:311a; (suppl 1, abstr)
  33. Kohlmann A, Schoch C, Dugas M, et al.  Gene expression profiles of distinct cytogenetic CLL subtypes. Blood. 2002;100:311a; (suppl 1, abstr)
  34. Kohlmann A, Schoch C, Schnittger S, et al: Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. (submitted)
  35. Kohlmann A, Schoch C, Schnittger S, et al.  Molecular characterization of acute leukemias using microarray technology. Genes Chromosomes Cancer. 2003;37:396–405
  36. Lipshutz RJ, Fodor SP, Gingeras TR, et al.  High density synthetic oligonucleotide arrays. Nat Genet. 1999;21:20–24
  37. Liu G, Loraine AE, Shigeta R, et al.  NetAffx (Affymetrix probesets and annotations). Nucleic Acids Res. 2003;31:82–86
  38. Liu WM, Mei R, Di X, et al.  Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics. 2002;18:1593–1599
  39. Lockhart DJ, Dong H, Byrne MC, et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996;14:1675–1680
  40. Miyazato A, Ueno S, Ohmine K, et al.  Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood. 2001;98:422–427
  41. Moos PJ, Raetz EA, Carlson MA, et al.  Identification of gene expression profiles that segregate patients with childhood leukemia. Clin.Cancer Res. 2002;8:3118–3130
  42. Ohmine K, Ota J, Ueda M, et al.  Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Oncogene. 2001;20:8249–8257
  43. Qian Z, Fernald AA, Godley LA, et al.  Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA. 2002;99:14925–14930
  44. Quackenbush J. Microarray data normalization and transformation. Nat Genet. 2002;32(suppl):496–501
  45. Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol. 2002;20:1932–1941
  46. Ramaswamy S, Tamayo P, Rifkin R, et al.  Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA. 2001;98:15149–15154
  47. Rosenwald A, Alizadeh AA, Widhopf G, et al.  Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639–1647
  48. Ross ME, Zhou X, Song G. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. 2003; Blood prepublished online May 1, www.bloodjournal.org
  49. Schmitz N, Kohlmann A, Schoch C, et al.  Gene expression profiling in acute promyelocytic leukemia (APL) with t(15;17) (Microarray analyses and validation of important genes using real time PCR). Blood. 2002;100:312a; (suppl 1, abstr)
  50. Schnittger S, Kohlmann A, Haferlach T, et al.  Acute myeloid leukemia (AML) with partial tandem duplication of the MLL-gene (MLL-PTD) can be discriminated from MLL-translocations based on specific gene expression profiles. Blood. 2002;100(suppl 1):312a
  51. Schnittger S, Schoch C, Dugas M, et al.  Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia (correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease). Blood. 2002;100:59–66
  52. Schoch C, Kern W, Kohlmann A, et al.  AML with complex aberrant karyotype can be distinguished from all other AML subtypes by gene expression profiles and are characterized by higher expression of genes involved in DNA repair. Blood. 2002;100:311a; (suppl 1, abstr)
  53. Schoch C, Kohlmann A, Schnittger S, et al.  Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA. 2002;99:10008–10013
  54. Slonim DK. From patterns to pathways (Gene expression data analysis comes of age). Nat Genet. 2002;32(suppl):502–508
  55. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet. 1999;21:5–9
  56. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med. 2003;348:1777–1785
  57. Stratowa C, Loffler G, Lichter P, et al.  CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer. 2001;91:474–480
  58. Vapnik V. Statistical Learning Theory. New York, NY: Wiley; 1998;
  59. Virtaneva K, Wright FA, Tanner SM, et al.  Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA. 2001;98:1124–1129
  60. Wiestner A, Rosenwald A, Barry TS, et al.  ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101:4944–4951
  61. Yagi T, Morimoto A, Eguchi M, et al.  Identification of a gene expression signature associated with prognosis of pediatric AML. Blood. 2003;102:1849–1856
  62. Yeoh EJ, Ross ME, Shurtleff SA, et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133–143
  63. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics. 2001;17:763–774
  64. Zhan F, Hardin J, Kordsmeier B, et al.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99:1745–1757

PII: S0037-1963(03)00193-8

doi: 10.1016/S0037-1963(03)00193-8

Seminars in Hematology
Volume 40, Issue 4 , Pages 281-295 , October 2003

Article Tools

* Image Usage & Resolution